BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2359900)

  • 1. [Spatial contrast sensitivity in multiple sclerosis].
    Vighetto A; Grochowicki M; Cousin J
    Rev Neurol (Paris); 1990; 146(4):264-70. PubMed ID: 2359900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
    Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
    Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visual evoked potentials, contrast sensitivity and color perception in patients with optic nerve neuritis and multiple sclerosis].
    Bürki E
    Klin Monbl Augenheilkd; 1981 Sep; 179(3):161-8. PubMed ID: 7300224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatic, spatial, and temporal losses of sensitivity in multiple sclerosis.
    Dain SJ; Rammohan KW; Benes SC; King-Smith PE
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):548-58. PubMed ID: 2318594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A neuro-ophthalmological analysis in 80 cases of multiple sclerosis].
    Tsuda H; Ishikawa H; Matsunaga H; Mizutani T
    Rinsho Shinkeigaku; 2004 Aug; 44(8):513-21. PubMed ID: 15471086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial contrast sensitivity in patients with multiple sclerosis.
    Carter R; Danta G
    Clin Exp Neurol; 1985; 21():233-47. PubMed ID: 3843223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
    Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
    Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
    J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of static perimetry in subclinical optic neuritis in multiple sclerosis].
    Mauguière F; Perret-Magloire E
    Rev Neurol (Paris); 1983; 139(12):745-52. PubMed ID: 6665389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
    Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial.
    Cole SR; Beck RW; Moke PS; Gal RL; Long DT
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1017-21. PubMed ID: 10752936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VISTECH contrast sensitivity and pattern-VEP in multiple sclerosis patients.
    Augustinus B; Van den Bergh L; Zeyen T
    Bull Soc Belge Ophtalmol; 1990; 236():89-96. PubMed ID: 2093410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
    Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
    Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical forms of optic neuritis of multiple sclerosis].
    Saraux H; Nordmann JP; Denis P
    J Fr Ophtalmol; 1991; 14(4):235-44. PubMed ID: 1955650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the central visual field by the Friedmann Mark I analyzer and color vision in 85 patients with multiple sclerosis. Correlation with visual evoked potentials in 50 cases].
    Grochowicki M; Vighetto A
    J Fr Ophtalmol; 1988; 11(1):61-5. PubMed ID: 3385126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inapparent visual field defects in multiple sclerosis patients.
    Vidović T; Cerovski B; Vidović DH; Cerovski J; Novak-Laus K
    Coll Antropol; 2005; 29 Suppl 1():67-73. PubMed ID: 16193681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous recording of pattern electroretinogram (PERG) and visual evoked potential (VEP) in multiple sclerosis.
    Stefano E; Cupini LM; Rizzo P; Pierelli F; Rizzo PA
    Acta Neurol Belg; 1991; 91(1):20-8. PubMed ID: 2028736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME; Haegerstrom-Portnoy G
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.